Target intelligence / Profile preview

Regulator of telomere elongation helicase 1 (RTEL1)

Target
RTEL1
Molecular classification
DNA helicase, XPD family helicase, Enzyme, Chromatin-associated protein, Genome stability factor
01

Overview

Regulator of telomere elongation helicase 1 (RTEL1) is an essential DNA helicase of the XPD family involved in the maintenance of telomere length and genome stability[2][5]. RTEL1 plays a critical role in resolving secondary DNA structures such as G-quadruplexes and t-loops at telomeres, facilitating telomere extension by telomerase, and supporting DNA replication and repair in both telomeric and nontelomeric regions[1][2][6]. Mutations in the RTEL1 gene cause telomere-related disorders such as Hoyeraal-Hreidarsson syndrome, characterized by accelerated telomere shortening, bone marrow failure, immunodeficiency, and developmental defects[1][3]. RTEL1 is also implicated in the pathogenesis of certain cancers and other diseases associated with genomic instability and defective telomere maintenance[5][6]. Experimental data show that expression levels of RTEL1 must be finely regulated; excess expression can be toxic to cells, likely due to disruption of telomere homeostasis[1][3]. No known drugs currently target RTEL1 directly, but its function may be relevant in the context of telomere biology-focused therapies and as a biomarker for telomere syndromes.

Other names
C20orf41KIAA1088Novel helicase-likeNHLDKFZP434C013DKCA4DKCB5PFBMFT3regulator of telomere elongation helicase 1regulator of telomere length
02

Biological functions

Telomere length regulationGenome stability maintenanceDNA replicationDNA repair (double-strand break repair)Resolution of G-quadruplex DNA structuresPrevention of telomere fragilityRegulation of TERRA (telomeric repeat-containing RNA) metabolism
03

Disease associations

CancerHoyeraal-Hreidarsson syndromeBone marrow failure syndromesDyskeratosis congenitaImmunodeficiencyOther telomere-related diseases
04

Safety considerations

Potential off-target effects or toxicity from RTEL1 overexpression (noted in gene therapy experiments)Genome instability if RTEL1 is inhibited or defective
05

Biomarkers

RTEL1 mutations (for diagnosing Hoyeraal-Hreidarsson syndrome and related telomere syndromes)Telomere length (for patient selection/monitoring)

Beyond the preview

Go deeper on Regulator of telomere elongation helicase 1 (RTEL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regulator of telomere elongation helicase 1 (RTEL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call